Mode
Text Size
Log in / Sign up
N/A Completed N=36 Randomized Treatment

Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit

Abdominal Surgery · thoracic surgery
Source: ClinicalTrials.gov NCT01823497 ↗
Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcomePrimary: Morphine Consumption — 0.014; 0.036 mg/kg/hr

Summary

The aim of this study is to examine the safety and effectiveness of 2 morphine delivery systems for post-surgical neonates. The investigators hypothesize that this study will be feasible to conduct, and that neonates receiving morphine via a Parent/Nurse Controlled Analgesia pump will receive less morphine and experience fewer side effects than neonates receiving morphine via continuous opioid infusion.

Outcome Measures

OutcomeResultp-value
PRIMARY
Morphine Consumption
0.014; 0.036
SECONDARY
Revised-Face, Legs, Activity, Cry, Consolability (Revised-FLACC) Scale
1.25; 1.67; 1.79; 1.083; 2.17; 1.83

Eligibility Criteria

Inclusion Criteria

  • Surgery Location:
  • Abdominal or Thoracic
  • First surgery only

Age:

  • Born ≥ 34-44 weeks post-menstrual age
  • Weight: Weight at birth or current weight ≥2 kg Intubated or extubated

Prior opioid exposure:

  • 2 day continuous exposure, must be off continuous drip for a week
  • Intermittent exposure ≤ 2 days prior to surgery Neonates exposed to chronic opioids in utero *In utero exposure to Selective Seretonin Reuptake Inhibitors and illicit drugs will be screened for and annotated.

At least 1 parent is English-speaking

Exclusion Criteria

  • Surgery Type:
  • Cardiac, Patent Ductus Arteriosus Ligation; Omphalocele (if intubated pre-operatively)

Diagnoses:

  • Necrotizing Enterocolitis; Diaphragmatic hernia (unless thoracoscopically repaired); Chemically or physiologically paralyzed Receiving vasopressors Receiving acetaminophen or a benzodiazepine (lorazepam or midazolam) ≤ 24 h before surgery Patients with any of the following: Epidural; Oscillating ventilator
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01823497). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search